论文部分内容阅读
目的：探讨幽门螺旋杆菌感染与胃癌的临床特征、病理学特征和分期之间的关系.方法：对我院自2010年1月至2013年12月收治的98例胃癌患者,用ABpH2.5-PAS及HE染色区别肠型和弥漫型胃癌,14C-尿素呼吸试验(14C-UBT)对Hp状态进行评估.
幽门螺旋杆菌感染与胃癌的临床特征、病理学特征和预后的相关性研究
【摘 要】
：
目的：探讨幽门螺旋杆菌感染与胃癌的临床特征、病理学特征和分期之间的关系.方法：对我院自2010年1月至2013年12月收治的98例胃癌患者,用ABpH2.5-PAS及HE染色区别肠型和弥漫型胃癌,14C-尿素呼吸试验(14C-UBT)对Hp状态进行评估.
【机 构】
：
内蒙古包头市肿瘤医院淋巴瘤乳腺肿瘤内科 包头肿瘤医院口腔科
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年4期
其他文献
Objective: Central nervous system (CNS) progression is frequently detected in patients with favorable initial responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs), but
Genome-wide screen of DNA methylation changes reveals GABBR2 as a novel potential treatment target f
Objective: Lung cancer is the leading cause of cancer related death in the world.The last decade has witnessed the rapid development of epidermal growth factor receptor (EGFR) directed targeted therap
PD-L1 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small C
Objective: Although neoadjuvant chemotherapy (NAC) for advanced lung cancer can improve operability and local disease control, the duration of benefit is limited before resistance develops.
Objective: The central nervous system (CNS) is a frequent site of progression in ALK+ NSCLC patients treated with crizotinib, thus good CNS efficacy is of crucial importance for new ALK inhibitors.
Determining the prevalence of EGFR mutations in patients with advanced non-small-cell lung cancer (a
Objective: IGNITE (a large, multinational, diagnostic, non-comparative, interventional study;NCT01788163) assessed EGFR mutation frequency in patients with advanced NSCLC of adenocarcinoma (ADC)/non-A
The role of postoperative adjuvant treatment in stageⅠB2/ⅡA2 cervical cancer patients with no pathol
目的： Bulky local tumor (≥4cm)is a poor prognostic factor for early stage cervical cancer patients.Most of the locally advanced cervical cancer patients need postoperative radiotherapy.
Stereotactic Radiotherapy (SRT) or Whole Brain Radiotherapy (WBRT) Alone versus SRT plus WBRT for Br
Objective: To perform ameta-analysis on diagnosed brain metastases patients treated with whole-brain radiotherapy (WBRT) and stereotactic radiotherapy (SRT) boost versus WBRT alone, or inpatients trea
Objective: As one of the major cancers with a high mortality rate, lung cancer is still a huge health challenge worldwide.Although platinum-based doublet chemotherapy is the most common therapeutic re
IMRT Improves Survival in Locally Advanced NSCLC (LA-NSCLC) Receiving Definitive Radiotherapy:A Popu
Objective: Currently intensity-modulated radiotherapy (IMRT) is regarded as a promising but unproven therapy for locally advanced non-small cell lung cancer (LA-NSCLC).
Activity of the c-Met inhibitor tepotinib (MSC2156119J) in combination with gefitinib in Asian patie
Objective: c-Met abnormalities can cause resistance to EGFR TKIs in EGFR mutant NSCLC patients (pts).The highly selective c-Met inhibitor tepotinib (MSC2156119J) had promising activity in a phase Ⅰ tr